Rosalind Advisors’s PolyPid PYPD Stock Holding History

Rosalind Advisors’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Sell	389,455 -208,471	-35%	-$961K	0.73%	24
2026 Q1	$2.62M	Sell	597,926 -98,630	-14%	-$436K	1.05%	20
2025 Q4	$3.02M	Sell	696,556 -222,112	-24%	-$825K	1.06%	23
2025 Q3	$3.06M	Sell	918,668 -56,794	-6%	-$197K	1.05%	26
2025 Q2	$3.44M	Sell	975,462 -42,559	-4%	-$125K	1.63%	21
2025 Q1	$2.76M	Hold	1,018,021	–	–	1.34%	22
2024 Q4	$3.09M	Buy	1,018,021 +338,853	+50%	+$1.11M	1.58%	20
2024 Q3	$2.34M	Buy	679,168 +262,368	+63%	+$943K	1.5%	19
2024 Q2	$1.79M	Buy	416,800 +1,000	+0.2%	+$4.47K	1.38%	21
2024 Q1	$1.91M	Buy	+415,800	New	+$2.51M	1.79%	20

Other funds holding PYPD

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Rosalind Advisors's PYPD Position: Q2 2026 in Review

Rosalind Advisors reduced its PolyPid (PYPD) stake by 35% in Q2 2026, selling an estimated $961K and leaving 389,455 shares worth $1.98M. The position accounts for 0.73% of the portfolio, ranked #24.

Rosalind Advisors first reported a position in PYPD in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.44M in Q2 2025. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

Rosalind Advisors held 389,455 shares of PolyPid worth $1.98M as of Q2 2026.
Rosalind Advisors sold 208,471 PolyPid shares in Q2 2026, an estimated $961K.
PolyPid made up 0.73% of Rosalind Advisors's portfolio in Q2 2026, its #24 holding.
Rosalind Advisors first reported a position in PolyPid in Q1 2024 and has held it in 10 quarters since.
Rosalind Advisors's PolyPid position peaked at $3.44M in Q2 2025.
33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.